Viral Special Pathogens Branch, the Centers for Disease Control and Prevention, Atlanta, GA, USA.
PLoS Negl Trop Dis. 2012 Jun;6(6):e1546. doi: 10.1371/journal.pntd.0001546. Epub 2012 Jun 26.
Ebola hemorrhagic fever (EHF) and Marburg hemorrhagic fever (MHF) are rare viral diseases, endemic to central Africa. The overall burden of EHF and MHF is small in comparison to the more common protozoan, helminth, and bacterial diseases typically referred to as neglected tropical diseases (NTDs). However, EHF and MHF outbreaks typically occur in resource-limited settings, and many aspects of these outbreaks are a direct consequence of impoverished conditions. We will discuss aspects of EHF and MHF disease, in comparison to the "classic" NTDs, and examine potential ways forward in the prevention and control of EHF and MHF in sub-Saharan Africa, as well as examine the potential for application of novel vaccines or antiviral drugs for prevention or control of EHF and MHF among populations at highest risk for disease.
埃博拉出血热(EHF)和马尔堡出血热(MHF)是罕见的病毒性疾病,流行于中非地区。与更为常见的原生动物、蠕虫和细菌疾病(通常被称为被忽视的热带病(NTDs))相比,EHF 和 MHF 的总体负担较小。然而,EHF 和 MHF 疫情通常发生在资源有限的环境中,这些疫情的许多方面都是贫困条件的直接后果。我们将讨论 EHF 和 MHF 疾病与“经典”NTDs 的区别,并探讨在撒哈拉以南非洲预防和控制 EHF 和 MHF 的潜在方法,以及检查新型疫苗或抗病毒药物在预防或控制高危人群中 EHF 和 MHF 的应用潜力。